Multiple Sclerosis: all 3,524 studies

Page 16 of 36. Open to participants first (668), then studies with results posted, then the rest; newest registration first within each.

• Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis PatientsActive, not recruitingNCT05902429Phase 4
• Effectiveness of Powerball System in People With Multiple SclerosisCompletedNCT05895734Not applicable
• Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And NeurodegenerationActive, not recruitingNCT05893225Phase 2
• MS Fatigue and tDCS on Fatigue in Multiple SclerosisCompletedNCT05890885Not applicable
• Investigation of the Effects of Local Vibration Applied to Different Regions and Spinal Stabilization ExercisesCompletedNCT05885282Not applicable
• Anti-inflammatory Diet Consultation for Those With Neuromuscular DisabilityCompletedNCT05881122Not applicable
• The Effect of the Level of Hand Fatigability on Multiple Sclerosis on General Fatigue and FunctionalityCompletedNCT05880745Not applicable
• Exergaming With Immersive Virtual Reality For People With Multiple Sclerosis (ExeRVIEM)CompletedNCT05870254Not applicable
• A Closed Loop, Doctor to Patient, Mobile Application for Depression in People With Multiple SclerosisActive, not recruitingNCT05865405Not applicable
• Effects of Physical Therapy and Dalfampridine on Functional Mobility in Non Ambulatory Persons With Multiple SclerosisCompletedNCT05859802Phase 2/3
• First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641CompletedNCT05853835Phase 1
• Evaluation of the Microbiome in Multiple SclerosisTerminatedNCT05844826Not applicable
• The Effect of Hope Placement Program on Dıagnosed Wıth MSStatus unknownNCT05840653Not applicable
• Multiple Sclerosis Falls Insight TrackActive, not recruitingNCT05837949Not applicable
• Clinical Investigation of the Quality of Life Benefit of Using a Home Walking Exoskeleton for a Population of Multiple Sclerosis Patients.CompletedNCT05835622Not applicable
• Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying TreatmentCompletedNCT05834335
• Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Receptor Modulators (S1PRM)TerminatedNCT05828901
• Mayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoCompletedNCT05826028
• Arm Swing During Walking in Early Multiple SclerosisCompletedNCT05821257
• Multiple Sclerosis and Fatigue AssessmentCompletedNCT05820334
• MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® DetectActive, not recruitingNCT05816122Not applicable
• Epstein Barr Virus Infection in Patients With Radiologically Isolated SyndromeCompletedNCT05815108
• Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis.CompletedNCT05811949
• Trabecular Bone Score in Multiple SclerosisCompletedNCT05811689
• Gut Microbiome and DepressionTerminatedNCT05808101
• A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)CompletedNCT05798520Phase 2
• Cladribine Tablets Level of Response Predictors in Clinical Practice (CLODINA)Active, not recruitingNCT05797740
• Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility StudyCompletedNCT05792176Not applicable
• Evaluation of a Self-management Programme to Prevent Falls in People With Multiple SclerosisCompletedNCT05789225Not applicable
• Walking and Thinking - Brain Activity During Complex Walking in People With Multiple SclerosisCompletedNCT05787704
• Muscle Vibration and Fatigue in Patients With MSStatus unknownNCT05783999Not applicable
• Demyelination and Remyelination in Multiple Sclerosis (MS) Detected by Brain Amyloid PET-CTCompletedNCT05783934Not applicable
• A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) ConditionActive, not recruitingNCT05781113
• Mechanical Determinants of Upper Limbs Oscillation During GaitCompletedNCT05778474
• Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis.TerminatedNCT05777902Phase 4
• Determination of Compliance to Mediterranean Diet, Impacts on Walking and Quality of Life in Multiple SclerosisStatus unknownNCT05777629
• A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)Active, not recruitingNCT05767736
• Czech Pharmaco-epidemiological Study on Disease Modifying DrugsCompletedNCT05762003
• Awareness of Osteoporosis in Multiple Sclerosis PatientsCompletedNCT05760651
• PURO - PUlmonary Rehabilitation With O-RAGT PlatformCompletedNCT05757830Not applicable
• WEBCAMS: Walking Exercise for Brain and Cognition in Adults With Multiple SclerosisActive, not recruitingNCT05755061Phase 1
• Pain in Neurorehabilitation Through Wearable Devices: an Exploratory StudyStatus unknownNCT05747040Not applicable
• Implication of 5-HT7 Receptor in Inflammatory Mechanisms in Multiple SclerosisCompletedNCT05746845
• Reliability and Validity of Outcome Measures for Pain in Multiple SclerosisCompletedNCT05742152
• The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis PatientsActive, not recruitingNCT05735067
• A Pilot Randomized Controlled Trial: CoINTEGRATECompletedNCT05732285Not applicable
• Dalfampridine in Egyptian Patients With Multiple SclerosisStatus unknownNCT05730738Not applicable
• At-Home Gait AssessmentCompletedNCT05724901
• Ultra-high-field Brain MRI in Multiple SclerosisCompletedNCT05718947
• Wearables for the Bladder: an In-home Treatment Feasibility Pilot StudyActive, not recruitingNCT05715268Not applicable
• Examining the Impact of an Online, Non-restrictive Diet Among Persons With Multiple SclerosisCompletedNCT05712408Not applicable
• Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)Status unknownNCT05705986
• A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple SclerosisActive, not recruitingNCT05704361Phase 1
• A Study of End of Dose Phenomena in Subcutaneous Natalizumab Treated Multiple Sclerosis (MS) ParticipantsTerminatedNCT05701423
• Multiple Sclerosis and Respiratory and Functional CapacityCompletedNCT05697523
• Cognitive Reserve-building Activities in Multiple SclerosisCompletedNCT05691192Phase 2
• A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their BabiesActive, not recruitingNCT05688436
• Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAMCompletedNCT05684016Not applicable
• Efficacy of Square- Stepping Exercises in Individuals With Multiple SclerosisCompletedNCT05682963Not applicable
• CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple SclerosisCompletedNCT05671055
• An Observational Biomarker Study in Multiple Sclerosis (MS) PatientsCompletedNCT05663853
• Validity and Reliability of Lower Extremity Position Test in Patients with Multiple SclerosisCompletedNCT05663541
• Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple SclerosisCompletedNCT05661266
• VIRtual Versus UsuAL In-office Care for Multiple Sclerosis (VIRTUAL-MS)Active, not recruitingNCT05660187Not applicable
• A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT05658601
• A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in ChinaCompletedNCT05658484Phase 4
• Peripheral Immunological Effects of High-dose Vitamin D Treatment in Healthy SubjectsCompletedNCT05654818Not applicable
• Silent Progression Activity Monitoring - SPAM StudyCompletedNCT05650281
• The Reliability and Validity of the L-test in Patients With Multiple SclerosisCompletedNCT05641714
• Physical Activity in Persons Newly Diagnosed With Multiple SclerosisCompletedNCT05641532Not applicable
• The Effect of Augmented Reality Based Telerehabilitation Application on Neuromuscular and Sensorimotor Parameters in Multiple Sclerosis PatientsStatus unknownNCT05639517Not applicable
• Effect of Vestibular Rehabilitation on Trunk Kinetic and Kinematic Parameters in Patients With Multiple SclerosisCompletedNCT05635890Not applicable
• Disability Level and Trunk Control in Individuals With Multiple SclerosisCompletedNCT05634993
• Sunlight-mediated Inter-organ Leukocyte ExchangeCompletedNCT05627609Not applicable
• The 'Wearing Off' Effect of DMTCompletedNCT05627271
• Feasibility and Effectiveness of a Mindfulness Program Delivered by Web to Patients During Hospitalization and Caregivers.CompletedNCT05623254Not applicable
• OFSEP Very High Definition CohortActive, not recruitingNCT05622643
• Effect of Bio-electromagnetic Energy Regulation Therapy on Erectile Dysfunction in Patients With Multiple SclerosisStatus unknownNCT05615454Not applicable
• The Effect of Motor Imagery on Balance in Persons With Multiple SclerosisStatus unknownNCT05615207Not applicable
• Telerehabilitation of Multidomain Cognitive Impairment in Multiple SclerosisTerminatedNCT05611047Not applicable
• Lesion Load and Location in Relation to Cognition, Fatigue and Physical Disability in RRMSCompletedNCT05604092
• Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and PainCompletedNCT05598736Not applicable
• Turkish Version of F-2-MSStatus unknownNCT05590533
• Neurogenic Lower Urinary Tract Symptoms in Patients With Multiple SclerosisStatus unknownNCT05587101
• Teleassessment in Ataxic Multiple SclerosisCompletedNCT05585541
• Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis.CompletedNCT05576779
• Neurostatus-SMARTCARE in Comparison to Standard Neurostatus-EDSS®CompletedNCT05575843Not applicable
• Effectiveness of Telerehabilitation Interventions in Multiple SclerosisStatus unknownNCT05571826
• Effect of Arm Ergometer Exercise Training on Upper Extremity Function in People With Multiple Sclerosis.Status unknownNCT05571631Not applicable
• Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other TherapiesCompletedNCT05566756
• "Evaluation of Usability and Safety of the Self-balancing Walking System Atalante in Patients With Multiple Sclerosis"CompletedNCT05563402Not applicable
• Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and PainCompletedNCT05562453Not applicable
• Transient and Immediate Motor Effects of Exercise in Progressive Multiple SclerosisStatus unknownNCT05562414Not applicable
• Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal BiomarkersCompletedNCT05561621
• High Intensity Interval Gait Training in Multiple SclerosisStatus unknownNCT05560880Not applicable
• The Effect of Transcranial Direct Current Stimulation on Fatigue Among Multiple Sclerosis Patients.PatientsStatus unknownNCT05560139Not applicable
• Effect of the Vojta Therapy in Patients Multiple SclerosisStatus unknownNCT05558683Not applicable
• In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory DiseasesCompletedNCT05544448Not applicable
• The Effect of Reflexology and Pelvic Floor Muscle Exercises (Kegel) on Urinary Incontinence in MS PatientsCompletedNCT05541965Not applicable
• DECISIve - DiagnosE Using the Central veIn SIgn v1.0CompletedNCT05533905

← Multiple Sclerosis overview